ClinicalTrials.Veeva

Menu

Enhanced Diagnostics for Early Detection of Atrial Fibrillation (DETECT-AF)

University Hospital Basel logo

University Hospital Basel

Status

Completed

Conditions

Atrial Fibrillation

Treatments

Device: ECG

Study type

Observational

Funder types

Other

Identifiers

NCT02270112
EKNZ:2014-080

Details and patient eligibility

About

Paroxysmal atrial fibrillation can only be diagnosed during episodes when the arrhythmia is present.

The investigators hypothesize that the activation of the atrial myocardium resulting in the p-wave of the ecg should display abnormalities in diseased atria which are vulnerable for AF.

Full description

In the first part of this trial different diagnostic techniques to detect arrythmogenic substrates of atrial fibrillation will be tested. If suitable parameters can be identified, a follow up trial to identify patients at risk for AF will be conducted before a stroke happens.

Parameters tested are

  1. Electrophysiological differences between patients with paroxysmal AF and no history of AF
  2. "Vascular Stiffness" detected by an iPhone app

All patients will undergo a cardiogoniometrie and a pulse wave analysis with an iPhone. Each exam takes 5 minutes.

Enrollment

287 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • paroxysmal atrial fibrillation in sinus rhythm at presentation

Exclusion criteria

  • acute cerebral trauma
  • antiarrhythmic medication

Trial design

287 participants in 1 patient group

Paroxysmal Af
Description:
No Intervention is planned. All patients receive a 5 Minute ECG and have their pulse recordes by an iPhone.
Treatment:
Device: ECG

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems